Research & Development
Pipeline Update
Pipeline Update
The product development process at EastPharma is customer and product-driven. In 2007, we introduced a range of products offering higher margins, such as new cardiovascular products, whilst increasing the current and future diversification of our portfolio.

Recent Product Launches 2005, 2006, 11 ‘07

Product Therapeutic
Category
Launch
Date
Originator
Brand Name
Market Size
($m)
Degra
Gineksin F
Trio
Tekfin
Melcam
Devasid
Devalud
Citrex
Luxat
Losapres Plus
Nimelid
Pirhot D
Coniel
Ketrodol
Colastin-l
Pandev
Devasid
Doxafin
Erectile Dysfunction Prd
Cereb/Periph Vasotheraps
Acid Pump Inhibitors
Topical Dermat Antifungal
Antirheumatics Non-s Pln
Broad Spect Penicill Oral
Muscle Relaxants.Central
Ssri Antidepressants
Antileuk Anti-asthm Sys
Angiotens-ii Antag. Comb
Antirheumatics Non-s Pln
Cold Preparations
Calcium Antagonists Plain
Ketorolac
Statins (Hmg-coa Red)
Acid Pump Inhibitors
Broad Spect Penicill OralDesloratadine
May-05
May-05
Oct-05
Oct-05
Oct-05
Mar-06
May-06
May-06
Dec-06
Dec-06
Dec-06
Dec-06
Jan-07
Jan-07
Feb-07
Mar-07
Jun-07
Sept-07
Viagra (Pfizer)
Tebokan (Ibrahim)
Helipak (Abbott)
Lamisil (Novartis)
Mobic (Boehringer Ing)
Duocid (Pfizer)
Sirdalud (Novartis)
Cipram (Lundbeck)
Singulair (Msd)
Hyzaar (Msd)
Mesulid (Pfizer)
Tylol Hot D (Nobel)
Coniel (Deva)
Toradol (Roche)
Lipitor (Pfizer)
Pantpas (Bayer)
Duocid (Pfizer)
Aerius (Schering Plough)
79.6
41.0
18.7
33.3
61.9
94.5
7.1
25.5
47.2
40.8
5.7
0.4
-
2.0
121.7
23.8
94.5
20.0


Source: IMS

A Large and Diversified Range of Products is currently being registered and will be Launched Over the Next Few Years


EastPharma Turkey offers 85 pharmaceutical products in 217 presentation forms


73 branded generics products in 198 presentation forms
12 licensed products in 19 presentation forms